Ad
related to: ionis stock forecast this week today news reporthugealerts.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
A week ago, Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) came out with a strong set of annual numbers that could... Ionis Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been ...
Ionis Pharmaceuticals Stock Price And Volume Action Ionis Pharmaceuticals (NASDAQ:IONS) is currently down 17.47% to a price of $46.29. Tuesday the stock has been traded at a volume of 2.55 million ...
For premium support please call: 800-290-4726 more ways to reach us
US stocks were mostly higher on Tuesday, led by the tech sector. Today marks the start of the Santa Claus trading window, a historically bullish 7-day stretch. The stock market will close at 1 p.m ...
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
Ionis (IONS) incurs wider-than-expected Q3 loss. The company maintains its top-and bottom-line guidance for 2021 Ionis (IONS) Q3 Earnings & Revenues Fall Short of Estimates
The decline on Monday comes as third-quarter earnings season nears its peak, with more than 100 S&P 500 companies set to report results this week, including Coca-Cola, Tesla, Boeing, and UPS.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Ad
related to: ionis stock forecast this week today news reporthugealerts.com has been visited by 10K+ users in the past month